Follow

Manuscripts from 2014

PDF

A randomized trial of bevacizumab for newly diagnosed glioblastoma., Mark R Gilbert, James J Dignam, Terri S Armstrong, Jeffrey S Wefel, Deborah T Blumenthal, Michael A Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie Pugh, Minhee Won, Robert Jeraj, Paul D Brown, Kurt A Jaeckle, David Schiff, Volker W Stieber, David G Brachman, Maria Werner-Wasik, Ivo W Tremont-Lukats, Erik P Sulman, Kenneth D Aldape, Walter J Curran, and Minesh P Mehta

PDF

A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect., Yunguang Sun; Carey Jeanne Myers; Adam Dicker MD, PhD; and Bo Lu, MD

PDF

microRNAs: The Short Link between Cancer and RT-Induced DNA Damage Response., Christopher M Wright; Tu Dan; Adam Dicker MD, PhD; and Nicole L Simone

Manuscripts from 2013

Link

Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis., Michael B Bernstein; Nitin Ohri; James W Hodge; Madhur Garg; William Bodner; Shalom Kalnicki; Adam Dicker, MD, PhD; and Chandan Guha

PDF

Optimizing parametrial aperture design utilizing HDR brachytherapy isodose distribution., Katherine L Chapman, Nitin Ohri, Timothy N Showalter, and Laura A Doyle

PDF

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610., Larry Pan, Seunghee Baek, Pamela R Edmonds, Mack Roach, Harvey Wolkov, Satish Shah, Alan Pollack, M Elizabeth Hammond, and Adam P Dicker

PDF

Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes., Kosj Yamoah, Kwamena Beecham, Sarah E Hegarty, Terry Hyslop, Timothy Showalter, and Joel Yarney

Manuscripts from 2012

PDF

Larynx-sparing techniques using intensity-modulated radiation therapy for oropharyngeal cancer., Voichita Bar-Ad, Haibo Lin, Wei-Ting Hwang, Curtiland Deville, Pinaki R Dutta, Zelig Tochner, and Stefan Both

PDF

Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas., Colin E Champ, Joshua Siglin, Mark V Mishra, Xinglei Shen, Maria Werner-Wasik, David W Andrews, Sonal U Mayekar, Haisong Liu, and Wenyin Shi

PDF

Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?, Colin E Champ, Jeff S Volek, Joshua Siglin, Lianjin Jin, and Nicole L Simone

PDF

Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planning., Laura Doyle, Adam J Hesney, Katherine L Chapman, Haisong Liu, Perry R Weiner, Adam Dicker, Yan Yu, and Timothy Showalter

PDF

Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma., Elana J Fertig; Qing Ren; Haixia Cheng; Hiromitsu Hatakeyama; Adam Dicker MD, PhD; Ulrich Rodeck; Michael Considine; Michael F Ochs; and Christine H Chung

PDF

Radiation Oncology at Thomas Jefferson University: A Specialty Emerges as a Department Evolves, Eric Gressen MD, Ben W. Corn MD, and Adam P Dicker

PDF

Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study., Xinglei Shen, David W Andrews, Robert C Sergott, James J Evans, Walter J Curran, Mitchell Machtay, Ruben Fragoso, Harriet Eldredge, Colin E Champ, Matthew Witek, Mark V Mishra, Adam P Dicker, and Maria Werner-Wasik

PDF

Radiation therapy for locally recurrent breast cancer., Joshua Siglin, Colin E Champ, Yelena Vakhnenko, Pramila R Anne, and Nicole L Simone

PDF

Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis., Nicholas George Zaorsky, Ninad Patil, Gary Mitchel Freedman, and Madalina Tuluc

Manuscripts from 2011

PDF

Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report., Shannon Fogh, Charles Glass, David W Andrews, and Maria Werner-Wasik

PDF

Early toxicity predicts long-term survival in high-grade glioma., Y. R. Lawrence, M Wang, Adam Dicker, David W Andrews, Walter J Curran, J M Michalski, L Souhami, W-Ka Yung, and M Mehta

Link

Safety considerations for IMRT: Executive summary., Jean M Moran, Melanie Dempsey, Avraham Eisbruch, Benedick A Fraass, James M Galvin, Geoffrey S Ibbott, and Lawrence B Marks

PDF

Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma., Xinglei Shen, Albert Denittis, Maria Werner-Wasik, Rita Axelrod, Paul Gilman, Thomas Meyer, Joseph Treat, Walter J Curran, and Mitchell Machtay

PDF

Vimentin is a novel AKT1 target mediating motility and invasion., Q-S Zhu; K Rosenblatt; K-L Huang; G Lahat; R Brobey; S Bolshakov; T Nguyen; Z Ding; R Belousov; K Bill; X Luo; A Lazar; Adam Dicker, MD, PhD; G B Mills; M-C Hung; and D Lev

Manuscripts from 2010

PDF

Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos., William R Davidson, Csaba Kari, Qing Ren, Borbala Daroczi, Adam P Dicker, and Ulrich Rodeck

PDF

FDG-PET staging and importance of lymph node SUV in head and neck cancer., Gregory J Kubicek, Collin Champ, Shannon Fogh, Fen Wang, Eashwer Reddy, Charles Intenzo, Reginald W Dusing, and Mitchell Machtay

PDF

Splenic infarction: an update on William Osler's observations., Yaacov R Lawrence, MA MBBS MRCP; Russell Pokroy, MB BCh; Daniel Berlowitz, MB BCh; Dvora Aharoni, MD; Daniel Hain, MD; and Gabriel S Breuer, MD

PDF

From survival to survivorship: late side effects become an issue in high-grade glioma., Yaacov R Lawrence, Wenyin Shi, and Adam P Dicker

PDF

Chart Rounds in the Digital Age: A Survey of North American Institutions, M. A. Whiton, A. P. Dicker, E. J. Wuthrick, L. Doyle, A. S. Harrison, and Y. R. Lawrence

Link

MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers., P Zhang, H Wang, P S N Rowe, B Hu, and Y Wang

Manuscripts from 2009

PDF

IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119., Gary A Ezzell; Jay W Burmeister; Nesrin Dogan; Thomas J LoSasso; James G Mechalakos; Dimitris Mihailidis; Andrea Molineu; Jatinder R Palta; Chester R Ramsey; Bill J Salter; Jie Shi; Ping Xia; Ning J Yue; and Ying Xiao, PhD

PDF

MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1., Shuang Liu, Hongyan Wang, Xiang Wang, Lin Lu, Ning Gao, Peter S N Rowe, Baocheng Hu, and Ya Wang

PDF

Recent trends in soft-tissue infection imaging., Nicholas Petruzzi, MD; Nylla Shanthly, MBBS, DRM; and Mathew L. Thakur, PhD

Link

Aggressive Trimodality Therapy for T1N2M1 Nonsmall Cell Lung Cancer with Synchronous Solitary Brain Metastasis: Case Report and Rationale., Timothy Showalter and Alexander Lin

PDF

Genomic biomarkers for molecular imaging: predicting the future., Mathew L. Thakur

PDF

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model., Phyllis Wachsberger, Randy Burd, Anderson Ryan, Constantine Daskalakis, and Adam P. Dicker

PDF

Initial Tumor Metabolic Parameters (Maximum SUV and Metabolic Volume) Predict Death From Lung Cancer and Rapid SUV Decline is Associated with Local Control, Maria Werner-Wasik, Edward Pequignot, Terry Hyslop, Brian Shulli, Ying Xiao, Mitchell Machtay, Amy Taylor, Walter Curran, and Rita Axelrod

PDF

In Reply to Dr. Hurkmans et al., Ying Xiao, PhD; Lech S. Papiez, PhD; and James M. Galvin, DSc

PDF

Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer., Ying Xiao, Lech Papiez, Rebecca Paulus, Robert Timmerman, William L. Straube, Walter R. Bosch, Jeff Michalski, and James M. Galvin

PDF

A real-time prostate cancer detection technique using needle insertion force and patient-specific criteria during percutaneous intervention, Kaiguo Yan, T. Podder, L. Li, J. Joseph, D. R. Rubens, E. M. Messing, L. Liao, and Y. Yu

Manuscripts from 2008

PDF

Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report., Timothy N Showalter, A Omer Nawaz, Frederick M Fellin, Pramila R Anne, Ernest L Rosato, and Adam P Dicker

PDF

Increasing tumor volume is predictive of poor overall and progression-free survival: Secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer, Maria Werner-Wasik, R. Suzanne Swann, Jeffrey Bradley, Mary Graham, Bahman Emami, James Purdy, and William Sause

PDF

Radioactive seed immobilization techniques for interstitial brachytherapy, K. Yan, T. Podder, I. Buzurovic, Y. Hu, E. Messing, D. Rubens, A. Dicker, R. Valicenti, N. Sarkar, W. Ng, and Y. Yu

Manuscripts from 2007

PDF

Robot-Assisted Prostate Brachytherapy, Yan Yu, Tarun Podder, Y D. Zhang, W S. Ng, V Misic, J Sherman, L Fu, D Fuller, D J. Rubens, J D. Strang, R A. Brasacchio, and E M. Messing

Manuscripts from 2006

PDF

Foreword: Anti-angiogenic therapy: Maximizing therapeutic gain, Adam P. Dicker

PDF

A phase II study of acute toxicity for Celebrex(TM) (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128, David K. Gaffney, Kathryn Winter, Adam P. Dicker, Brigitte Miller, Patricia J. Eifel, Janice Ryu, Vilija Avizonis, Mitch Fromm, and Kathryn Greven

PDF

Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos, Mary Frances McAleer, Kevin T. Duffy, William R. Davidson, Gabor Kari, Adam P. Dicker, Ulrich Rodeck, and Eric Wickstrom

PDF

The effect of Hus1 on ionizing radiation sensitivity is associated with homologous recombination repair but is independent of non-homologous end-joining , Robert S. Weiss, Xiang Wang, Baocheng Hu, and Ya Wang

Manuscripts from 2001

PDF

Department of Radiation Oncology and Kimmel Cancer Center, Thomas jefferson University, The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia., Anna Marsh, Amanda B Spurdle, Bruce C Turner, Sian Fereday, Heather Thorne, Gulietta M Pupo, Graham J Mann, John L Hopper, Joseph F Sambrook, and Georgia Chenevix-Trench

PDF

Cellular Senescence: Ex Vivo p53-Dependent Asymmetric Cell Kinetics., Lakshmi Rambhatla, Shirley A. Bohn, Patrizia B. Stadler, Jonathan T. Boyd, Ronald A. Coss, and James L. Sherley